Magnetic Resonance Contrast Activity
- Magnetic Resonance Contrast Activity
- Accession Number
Drug Drug Description Gadodiamide A gadolinium-based contrast agent used for the visualization of lesions with vascularity during magnetic resonance imaging (MRI) scans. Gadopentetic acid A gadolinium compound used as a contrast agent in MRIs. Gadoversetamide A gadolinium compound used as a contrast agent in MRI tests of the brain, spine, and liver. Gadoxetic acid A gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to help characterize lesions in the liver. Ferumoxytol An intravenous iron replacement product used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), or in patients who are unable to tolerate or who have not responded adequately to oral iron supplementation. Gadofosveset trisodium An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease. Gadoteridol A medication used to improve the contrast of MRI scans for better visualization. Gadobenic acid A gadolinium compound used as a contrast agent in MRIs. Mangafodipir An organ-specific paramagnetic contrast agent indicated for the imaging of the hepatobiliary system and detecting lesions in the liver and pancreas. Manganese A transition metal used for supplementation of manganese during Total Parenteral Nutrition (TPN). Gadobutrol A contrast agent used during diagnostic procedures to visualize disrupted areas of blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system. Gadolinium cation (3+) Not Annotated Gadopiclenol A gadolinium-based contrast agent (GBCA) used with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity.
- Drugs & Drug Targets